Scholarlink

Background <p>Congenital myasthenic syndromes represent a heterogenous group of rare genetic disorders that affect the neuromuscular junction. They present with variable combinations of extraocular, facial, bulbar, and limb muscle weakness with typical diurnal fluctuations of symptoms, with increased risk of sleep-related disorders. Due to the variable course, clinical diagnosis can be challenging and delayed, sometimes for decades.</p> Case presentation <p>We present the case of a 5-year-old girl presumed to have benign infantile hypotonia, who exhibited head drop during intercurrent illnesses and increased evening fatigue. Intermittent bilateral ptosis, initially unreported by the family and not observed during early morning examinations, became evident during a late afternoon visit. Given the clinical suspicion of a congenital myasthenic syndrome, genetic testing was performed and identified a homozygous pathogenic variant in the <i>RAPSN</i> gene responsible for a post-synaptic form of congenital myasthenia. Due to the complaints of excessive night-time snoring, overnight polygraphies (PG) were performed, revealing obstructive sleep-apnoea secondary to oropharyngeal muscle weakness. Symptomatic treatment with pyridostigmine, including a night-time dose, was followed by drastic improvement and near-complete resolution of nocturnal symptoms.</p> Conclusion <p>Congenital myasthenia may be more prevalent than recognised, with milder phenotypes still frequently overlooked or misdiagnosed. Sleep apnea is an important comorbidity that should be actively investigated. Optimised pyridostigmine therapy, including nocturnal dosing, can significantly alleviate symptoms and improve quality of life.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Late diagnosis of RAPSN mutation–associated congenital myasthenic syndrome with obstructive sleep apnea in a 5-year-old girl

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月3日

查看全文
  • Grace S. Kurian,
  • Thomas Rio Frio,
  • Isabelle Ruchonnet-Métrailler,
  • Joel Fluss

摘要

Background

Congenital myasthenic syndromes represent a heterogenous group of rare genetic disorders that affect the neuromuscular junction. They present with variable combinations of extraocular, facial, bulbar, and limb muscle weakness with typical diurnal fluctuations of symptoms, with increased risk of sleep-related disorders. Due to the variable course, clinical diagnosis can be challenging and delayed, sometimes for decades.

Case presentation

We present the case of a 5-year-old girl presumed to have benign infantile hypotonia, who exhibited head drop during intercurrent illnesses and increased evening fatigue. Intermittent bilateral ptosis, initially unreported by the family and not observed during early morning examinations, became evident during a late afternoon visit. Given the clinical suspicion of a congenital myasthenic syndrome, genetic testing was performed and identified a homozygous pathogenic variant in the RAPSN gene responsible for a post-synaptic form of congenital myasthenia. Due to the complaints of excessive night-time snoring, overnight polygraphies (PG) were performed, revealing obstructive sleep-apnoea secondary to oropharyngeal muscle weakness. Symptomatic treatment with pyridostigmine, including a night-time dose, was followed by drastic improvement and near-complete resolution of nocturnal symptoms.

Conclusion

Congenital myasthenia may be more prevalent than recognised, with milder phenotypes still frequently overlooked or misdiagnosed. Sleep apnea is an important comorbidity that should be actively investigated. Optimised pyridostigmine therapy, including nocturnal dosing, can significantly alleviate symptoms and improve quality of life.